Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2258 | 2233 | 26.9 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RIBA | Author keyword | 26 | 59% | 1% | 29 |
| 2 | ANTI HCV | Author keyword | 23 | 30% | 3% | 64 |
| 3 | NON A NON B HEPATITIS | Author keyword | 13 | 34% | 1% | 30 |
| 4 | HCV RNA | Author keyword | 12 | 16% | 3% | 70 |
| 5 | POSTTRANSFUSION HEPATITIS | Author keyword | 10 | 44% | 1% | 18 |
| 6 | ANTI HCV IGM | Author keyword | 10 | 73% | 0% | 8 |
| 7 | NON B HEPATITIS | Author keyword | 9 | 41% | 1% | 17 |
| 8 | RECOMBINANT IMMUNOBLOT ASSAY | Author keyword | 9 | 55% | 0% | 11 |
| 9 | ANTIBODIES TO HCV | Author keyword | 6 | 100% | 0% | 4 |
| 10 | RIBA 2 | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RIBA | 26 | 59% | 1% | 29 | Search RIBA | Search RIBA |
| 2 | ANTI HCV | 23 | 30% | 3% | 64 | Search ANTI+HCV | Search ANTI+HCV |
| 3 | NON A NON B HEPATITIS | 13 | 34% | 1% | 30 | Search NON+A++NON+B+HEPATITIS | Search NON+A++NON+B+HEPATITIS |
| 4 | HCV RNA | 12 | 16% | 3% | 70 | Search HCV+RNA | Search HCV+RNA |
| 5 | POSTTRANSFUSION HEPATITIS | 10 | 44% | 1% | 18 | Search POSTTRANSFUSION+HEPATITIS | Search POSTTRANSFUSION+HEPATITIS |
| 6 | ANTI HCV IGM | 10 | 73% | 0% | 8 | Search ANTI+HCV+IGM | Search ANTI+HCV+IGM |
| 7 | NON B HEPATITIS | 9 | 41% | 1% | 17 | Search NON+B+HEPATITIS | Search NON+B+HEPATITIS |
| 8 | RECOMBINANT IMMUNOBLOT ASSAY | 9 | 55% | 0% | 11 | Search RECOMBINANT+IMMUNOBLOT+ASSAY | Search RECOMBINANT+IMMUNOBLOT+ASSAY |
| 9 | ANTIBODIES TO HCV | 6 | 100% | 0% | 4 | Search ANTIBODIES+TO+HCV | Search ANTIBODIES+TO+HCV |
| 10 | RIBA 2 | 6 | 100% | 0% | 4 | Search RIBA+2 | Search RIBA+2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NON B HEPATITIS | 139 | 18% | 31% | 703 |
| 2 | RECOMBINANT IMMUNOBLOT ASSAY | 122 | 65% | 5% | 117 |
| 3 | NON A | 113 | 16% | 30% | 659 |
| 4 | NON A HEPATITIS | 69 | 34% | 7% | 167 |
| 5 | VIRAL SEQUENCES | 48 | 45% | 4% | 81 |
| 6 | POSTTRANSFUSION HEPATITIS | 34 | 18% | 8% | 174 |
| 7 | POST TRANSFUSION HEPATITIS | 32 | 41% | 3% | 60 |
| 8 | 2ND GENERATION ASSAYS | 21 | 55% | 1% | 26 |
| 9 | CIRCULATING ANTIBODIES | 20 | 26% | 3% | 66 |
| 10 | TRANSFUSION TRANSMITTED VIRUSES | 18 | 55% | 1% | 22 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE | 5 | 17% | 1% | 26 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Distribution of markers of hepatitis C virus infection throughout the body | 2000 | 65 | 87 | 43% |
| HEPATITIS-C AND HEPATOCELLULAR-CARCINOMA | 1995 | 104 | 56 | 64% |
| TO C OR NOT TO C - THESE ARE THE QUESTIONS | 1995 | 246 | 64 | 28% |
| HEPATITIS-C VIRUS 6 YEARS ON | 1994 | 186 | 28 | 25% |
| HEPATITIS-C - DIAGNOSTIC ASSAYS | 1995 | 43 | 26 | 69% |
| Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection | 2013 | 3 | 13 | 46% |
| Studies of non-A, non-B hepatitis and characterization of the hepatitis C virus in chimpanzees | 2000 | 19 | 48 | 50% |
| The long and winding road leading to the identification of the hepatitis C virus | 2009 | 28 | 64 | 25% |
| EPIDEMIOLOGY OF HEPATITIS-C IN THE EAST | 1995 | 68 | 115 | 42% |
| NON-A, NON-B-HEPATITIS .1. RECOGNITION, EPIDEMIOLOGY, AND CLINICAL-FEATURES | 1983 | 537 | 69 | 43% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HLTH COUNCIL JALISCO STATE | 3 | 100% | 0.1% | 3 |
| 2 | FIRC UNIV UNIT LIVER CANC | 2 | 67% | 0.1% | 2 |
| 3 | VIRUS SEROL UNIT | 2 | 67% | 0.1% | 2 |
| 4 | CENT BLOOD BANK | 1 | 31% | 0.2% | 4 |
| 5 | STUDY BLOOD BORNE AGENTS | 1 | 100% | 0.1% | 2 |
| 6 | ANGELA MARIA ANTONIO MIGLIAVACCA LIVER DIS | 1 | 33% | 0.1% | 3 |
| 7 | MED ANAT 3 | 1 | 40% | 0.1% | 2 |
| 8 | CENT SAUDE PUBL ESTADO BAHIA | 1 | 50% | 0.0% | 1 |
| 9 | CHAIR GASTROENTEROL HUMAN NUTR | 1 | 50% | 0.0% | 1 |
| 10 | CQFD VIROL | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000232862 | ACUTE HEPATITIS C//INTRAFAMILIAL TRANSMISSION//MOTHER TO INFANT TRANSMISSION |
| 2 | 0.0000208989 | HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1 |
| 3 | 0.0000188398 | CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA |
| 4 | 0.0000186477 | OCCULT HCV//OCCULT HEPATITIS C//OCCULT HCV INFECTION |
| 5 | 0.0000145370 | HCV CORE ANTIGEN//HCV CORE ANTIGEN ASSAY//HCV RNA STABILITY |
| 6 | 0.0000141393 | LIVER KIDNEY DIS TRANSPLANTAT//HCV VIREMIA//NOSOCOMIAL TRANSMISSION |
| 7 | 0.0000129902 | OCCULT HBV INFECTION//ANTI HBC//OCCULT HEPATITIS B VIRUS INFECTION |
| 8 | 0.0000106941 | CHIRURG D//ALCOHOLIC LIVER DISEASE ALD//CHRONIC HEPATITIS INDUCED BY ALCOHOL |
| 9 | 0.0000069227 | LOOKBACK//ANC HEP//BLOOD BORNE TRANSMISSION |
| 10 | 0.0000068211 | TUBULORETICULAR STRUCTURES//TUBULORETICULAR INCLUSIONS//RIBOSOME LAMELLA COMPLEXES |